Rafferty Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.91M Sell
124,723
-37,220
-23% -$809K 0.01% 520
2025
Q4
$3.4M Buy
161,943
+20,121
+14% +$351K 0.01% 530
2025
Q3
$2.18M Buy
141,822
+15,777
+13% +$207K 0.01% 631
2025
Q2
$1.18M Sell
126,045
-45,496
-27% -$501K ﹤0.01% 732
2025
Q1
$2.11M Sell
171,541
-6,624
-4% -$93.4K 0.01% 568
2024
Q4
$2.36M Buy
178,165
+6,643
+4% +$114K 0.01% 599
2024
Q3
$3.3M Sell
171,522
-6,398
-4% -$132K 0.01% 511
2024
Q2
$3.65M Sell
177,920
-195,318
-52% -$4.09M 0.01% 483
2024
Q1
$8.88M Sell
373,238
-30,143
-7% -$672K 0.03% 310
2023
Q4
$8.72M Buy
403,381
+119,257
+42% +$1.83M 0.04% 316
2023
Q3
$4.13M Sell
284,124
-51,223
-15% -$969K 0.02% 435
2023
Q2
$7.02M Buy
335,347
+52,464
+19% +$1.09M 0.04% 340
2023
Q1
$5.97M Buy
282,883
+18,121
+7% +$451K 0.04% 342
2022
Q4
$6.74M Buy
264,762
+118,380
+81% +$2.76M 0.06% 310
2022
Q3
$3.52M Buy
146,382
+68,478
+88% +$1.54M 0.04% 390
2022
Q2
$1.5M Sell
77,904
-52,575
-40% -$876K 0.01% 539
2022
Q1
$2.27M Sell
130,479
-27,353
-17% -$461K 0.01% 567
2021
Q4
$3.46M Buy
157,832
+84,100
+114% +$1.55M 0.02% 506
2021
Q3
$1.41M Sell
73,732
-64,440
-47% -$1.07M 0.01% 729
2021
Q2
$2.37M Sell
138,172
-7,269
-5% -$133K 0.01% 632
2021
Q1
$3.25M Buy
145,441
+127,618
+716% +$2.88M 0.02% 434
2020
Q4
$396K Sell
17,823
-8,573
-32% -$178K ﹤0.01% 738
2020
Q3
$390K Buy
+26,396
New +$402K ﹤0.01% 745

Other funds holding SNDX